Denali Advisors LLC bought a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 16,409 shares of the company's stock, valued at approximately $443,000. Denali Advisors LLC owned approximately 0.09% of USANA Health Sciences at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Pzena Investment Management LLC lifted its stake in shares of USANA Health Sciences by 0.7% in the 1st quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company's stock valued at $29,537,000 after purchasing an additional 8,110 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of USANA Health Sciences by 2.7% in the 1st quarter. Principal Financial Group Inc. now owns 55,076 shares of the company's stock valued at $1,485,000 after purchasing an additional 1,473 shares during the last quarter. Teacher Retirement System of Texas bought a new stake in shares of USANA Health Sciences in the 1st quarter valued at approximately $888,000. Robeco Institutional Asset Management B.V. lifted its stake in shares of USANA Health Sciences by 27.1% in the 1st quarter. Robeco Institutional Asset Management B.V. now owns 18,223 shares of the company's stock valued at $491,000 after purchasing an additional 3,887 shares during the last quarter. Finally, Exchange Traded Concepts LLC lifted its stake in shares of USANA Health Sciences by 7.1% in the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock valued at $248,000 after purchasing an additional 606 shares during the last quarter. Hedge funds and other institutional investors own 54.25% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Get Our Latest Report on USANA Health Sciences
USANA Health Sciences Stock Performance
USNA stock traded up $1.03 on Tuesday, hitting $31.32. 60,838 shares of the company's stock were exchanged, compared to its average volume of 141,690. The firm has a 50 day moving average price of $30.64 and a two-hundred day moving average price of $30.12. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $46.44. The stock has a market cap of $583.18 million, a P/E ratio of 17.21, a price-to-earnings-growth ratio of 0.97 and a beta of 0.64.
USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.70 by $0.03. USANA Health Sciences had a return on equity of 8.94% and a net margin of 3.98%. The company had revenue of $249.54 million during the quarter, compared to analysts' expectations of $243.08 million. During the same quarter in the prior year, the firm posted $0.86 EPS. Sell-side analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The disclosure for this sale can be found here. Insiders sold 12,013 shares of company stock valued at $360,149 over the last 90 days. Company insiders own 0.63% of the company's stock.
USANA Health Sciences Company Profile
(
Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
